Kalderos delivers technology that solves the challenges facing the US healthcare system in the drug discount space. We work with healthcare providers, drug manufacturers, payers, and government agencies alike to increase transparency and restore trust — enabling everyone to focus on improving the health of people.
At Kalderos, we develop technology solutions with a focus on simplifying the complex coordination of drug discount programs from exhaustive data services to intelligent reporting to issue resolution.
How We Do It
We work with many groups throughout the prescription drug supply chain to bring transparency and restore trust in the drug discount space.
At Kalderos, we believe that even the most difficult challenges in healthcare can be overcome with a combination of grit, determination, and creativity.
We are industry experts, user-centered designers, and data scientists. We apply the power of insight, design, and analytics to develop powerful solutions that delight our users and transform the business of healthcare.
Founder & CEO
Jeremy Docken is a founder and the CEO of Kalderos. His deep expertise in both 340B and Medicaid has given him a unique perspective on the issue of 340B duplicate discounts and how the problem may be solved in a manner that works for all stakeholders. Jeremy can frequently be found speaking at industry conferences or attending meetings with a wide variety of program stakeholders.
Founder & CIO
Jim is a founder and Chief Information Officer at Kalderos. Jim is an IT professional with extensive experience in developing and executing IT strategies that support overall business growth and productivity initiatives. At Kalderos, Jim works to align business and technical requirements for critical IT initiatives and creates smart and workable solutions to complex problems.
Founder & CTO
Dave is a founder and the Chief Technology Officer at Kalderos. He's a software development professional who's been designing, architecting and building innovative software systems for more than twenty years. Dave is passionate about technology and driven by the challenge and adventure of finding and implementing the most appropriate solutions for bringing Kalderos' business value to market.
James William Schuyler III
James Schuyler is the Chief Design & Strategy Officer at Kalderos. James has extensive experiences delivering innovative products, services, and experiences across a number of industries including healthcare. He is an expert in design thinking and user-centered design methodologies and focuses on delivering impactful design to everything that Kalderos does.
Micah Litow is the Chief Operating Officer at Kalderos. Micah is a commercialization professional with more than a dozen global product launches including consumables, capital equipment, and software solutions all in healthcare. Micah is passionate about our mission of increasing transparency and restoring trust across all parties in the healthcare ecosystem.
Steve Zielinski, RPh
Director, Industry Relations
Steve is a Director of Industry Relations at Kalderos. With a combination of Pharmaceutical experience and industry knowledge, Steve’s focus is on ensuring industry stakeholders understand Kalderos’ strategic marketplace objectives and help to align their needs with Kalderos’ solutions.
Join Our Team.
We are currently growing and looking for talented individuals to join the Kalderos team. If you are interested, please follow the link below.
Kalderos in the News>
“Kalderos’ $7 million Series A funding was part of a big fundraising month for Chicago tech companies and will help Kalderos create the first drug discount management solution.”American Inno – May 30, 2019
“Kalderos raised $7 million from Mercato Partners and plans to expand its team and scale its first-to-market technology platform for additional markets.“Built In Chicago – May 8, 2019
“Kalderos stands out as an innovator in the Chicago tech community with its purpose-driven initiative to solve for some of the most complex problems in the drug discount infrastructure.“Built In Chicago – June 25, 2019